Login / Signup

Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital.

Javier Torres-JiménezJ Esteban-VillarrubiaP García-AbellásA Cortés-SalgadoA Soria-RivasP Gajate-BorauM E Olmedo-GarcíaE Corral-de la FuenteY Lage-AlfrancaA Gómez-RuedaA Benito-BerlinchesL Gorospe-SarasuaP Garrido-López
Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
Management of SLR lacks a consensus recommendation, although corticosteroids and/or stopping the ICI are generally implemented. The potential consequences of stopping anticancer treatment should be taken into consideration, particularly in the absence of clear management recommendations.
Keyphrases
  • healthcare
  • papillary thyroid
  • squamous cell carcinoma
  • risk assessment
  • squamous cell
  • combination therapy